Pharma's Almanac

631 Articles Available

1 27

CDMO Service and Capacity Expansion

Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing

PR-M05-23-01

RNA Manufacturing

Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.

PR-M04-23-01

Biomanufacturing

Biologics Outsourcing: Decision Drivers and Key Considerations

PAO-04-23-CL-01

Microbiome Therapeutic Innovation

Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future

PAO-03-23-CL-08

Consulting

Supporting Drug Development – Increasing Probability of Success

PAO-03-23-CL-04

CDMO Leadership Award

Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards

PR-M03-23-04

New R&D Center

Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy

PAO-02-23-CL-07

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

PAO-02-23-CL-09

UN Global Compact

CDMO Joins United Nations Global Compact

PR-M03-23-02

CDMO Leadership Award

Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise

PR-M03-23-01

Scale-Up

Scale-Up Expertise to Support Your Biologics Life Cycle

PAO-02-23-CL-06

New CDMO Facility

Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare

PAO-02-23-PATV-04

Biomanufacturing

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

PAO-01-23-CL-04

Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

PAO-01-23-CL-03

Quality by Design

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

PAO-11-022-CL-06

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

PAO-11-022-CL-17

Biomanufacturing

Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion

PR-M12-22-02

PLIs

A Strategic Approach to Pre-License Inspections

PAO-11-022-CL-03

Microbiome-Based CDMO

Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

PAO-11-022-CL-13

CDMO

Goodwin Biotechnology Inc. is Now GBI, as Part of their Rebranding Initiative on Their 30-Year Anniversary!

PR-M12-22-02

Biomanufacturing

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

PAO-11-022-CL-11

New cGMP Facility

Alcami Builds cGMP Biostorage Facility in North Carolina

PR-M12-22-01

Cell Line Development Technology

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

PR-M11-22-09

Olon, International API Supplier, Releases New 2022 Sustainability Report

PR-M11-22-08

1 27

CDMO

631 Articles Available

Can't find what you're looking for? Try our advanced search.

CDMO Service and Capacity Expansion

Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing

RNA Manufacturing

Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.

Biomanufacturing

Biologics Outsourcing: Decision Drivers and Key Considerations

Microbiome Therapeutic Innovation

Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future

Consulting

Supporting Drug Development – Increasing Probability of Success

CDMO Leadership Award

Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards

New R&D Center

Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

UN Global Compact

CDMO Joins United Nations Global Compact

CDMO Leadership Award

Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise

Scale-Up

Scale-Up Expertise to Support Your Biologics Life Cycle

New CDMO Facility

Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare

Biomanufacturing

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Quality by Design

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Biomanufacturing

Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion

PLIs

A Strategic Approach to Pre-License Inspections

Microbiome-Based CDMO

Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

CDMO

Goodwin Biotechnology Inc. is Now GBI, as Part of their Rebranding Initiative on Their 30-Year Anniversary!

Biomanufacturing

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

New cGMP Facility

Alcami Builds cGMP Biostorage Facility in North Carolina

Cell Line Development Technology

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

Olon, International API Supplier, Releases New 2022 Sustainability Report